Krüger et al. demonstrated that the loss of endothelial FTO protected patients from obesity-induced insulin resistance, hyperglycemia, and hypertension in the presence of adipose tissue inflammation and obesity. The gene discussed is FTO; the disease is Hyperglycemia.